Eli Lilly's fast-growing blood cancer drug Jaypirca has bagged a new FDA approval as an earlier treatment for relapsed or ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of ...

Jaypirca was approved for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who were previously treated with a covalent Bruton ...

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval to ...

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.

Bruton’s tyrosine kinase inhibitors such as ibrutinib have significantly improved outcomes for chronic lymphocytic leukemia, ...

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted approval to ...

The FDA has granted traditional approval to pirtobrutinib (Jaypirca) for the treatment of adult patients with relapsed or ...

Dagny and I visited the Goodwill for the first time in a while. We were on the hunt for treasures that we could buy and flip ...

Following the expanded approval, the accelerated approval for the later-line CLL/SLL was converted to a traditional approval.

Thrombotic risk with PICCs matched that of totally implantable venous access devices, showing comparable long-term safety.

I visited Antiques Marketplace of Lemoyne to see what new treasures I could find. As soon as I arrived, I stumbled across ...